Smad3 Couples Pak1 With the Antihypertrophic Pathway Through the E3 Ubiquitin Ligase, Fbxo32.
Pathological cardiac hypertrophy is regarded as a critical intermediate step toward the development of heart failure. Many signal transduction cascades are demonstrated to dictate the induction and progression of pathological hypertrophy; however, our understanding in regulatory mechanisms responsib...
Main Authors: | Tsui, H, Zi, M, Wang, S, Chowdhury, S, Prehar, S, Liang, Q, Cartwright, E, Lei, M, Liu, W, Wang, X |
---|---|
Format: | Journal article |
Language: | English |
Published: |
American Heart Association
2015
|
Similar Items
-
Pak1 as a novel therapeutic target for antihypertrophic treatment in the heart.
by: Liu, W, et al.
Published: (2011) -
Role of the ubiquitin-proteasome pathway in the inner ear : identification of an E3 ubiquitin ligase for Atoh1
by: Cheng, Yen-Fu
Published: (2015) -
The role of E3 ubiquitin ligases in the development and progression of glioblastoma
by: Humphreys, LM, et al.
Published: (2021) -
Ubiquitin ligases: guardians of mammalian development
by: Cruz Walma, DA, et al.
Published: (2022) -
Computational development of E3 ubiquitin ligase binding moieties in PROTACs
by: Lam, Hilbert Yuen In
Published: (2024)